Molecular pharmacology of cancer therapy in human colorectal cancer by gene expression profiling

Autor: Paul Clarke, Ml, George, Easdale S, Cunningham D, Ri, Swift, Me, Hill, Dm, Tait, Workman P

Publikováno v: Europe PubMed Central

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1ce8f8379eacf8c45e86d3cca21daeef
http://europepmc.org/abstract/med/14583483

Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer

Autor: Rosalind Eeles, Dm, Tait, Mj, Peckham

Publikováno v: Europe PubMed Central

Lhermitte's sign is reported in 14 patients receiving chemotherapy for metastatic testicular cancer. In six patients the typical symptoms appeared during chemotherapy: in five patients within 1 month of treatment and in one patient at 2 months. The d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::710de19ff3bbea18f7aafe0ba770582f
http://europepmc.org/abstract/med/2424594

Pelvic Intensity-modulated Radiotherapy: Can we Better Quantify the Late Side-effects?

Autor: De Francesco I; Department of Radiotherapy, Royal Marsden Hospital, Sutton, Surrey, UK; Department of Radiotherapy, Policlinico Umberto I 'Sapienza' University of Rome, Rome, Italy., Thomas K; Department of Medical Statistics, Royal Marsden Hospital, Sutton, Surrey, UK., Tait DM; Department of Radiotherapy, Royal Marsden Hospital, Sutton, Surrey, UK.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2015 Jul; Vol. 27 (7), pp. 428. Date of Electronic Publication: 2015 Feb 26.

Cardiac volume effects during chemoradiotherapy for esophageal cancer (Regarding Lutkenhaus et al. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer).

Autor: Edmunds K; Joint Department of Physics, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom. Electronic address: katie.edmunds@rmh.nhs.uk., Brooks C; Joint Department of Physics, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Hansen VN; Joint Department of Physics, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, United Kingdom., Harris V; Department of Radiotherapy, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom., Tait DM; Department of Radiotherapy, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2015 Jan; Vol. 114 (1), pp. 128-9. Date of Electronic Publication: 2014 Dec 10.

Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.

Autor: Yu SK; Radiotherapy Department, Royal Marsden NHS Foundation Trust, Sutton/London, United Kingdom., Chand M; Colorectal Research Fellow, Department of Colorectal Surgery, Croydon University Hospital, Croydon CR7 7YE, United Kingdom; Radiology Department, Royal Marsden NHS Foundation Trust, London, United Kingdom., Tait DM; Radiotherapy Department, Royal Marsden NHS Foundation Trust, Sutton/London, United Kingdom., Brown G; Radiology Department, Royal Marsden NHS Foundation Trust, London, United Kingdom. Electronic address: gina.brown@rmh.nhs.uk.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2014 Mar; Vol. 50 (5), pp. 920-7. Date of Electronic Publication: 2014 Jan 15.